Krystal Biotech Inc (KRYS)
177.39
-6.83
(-3.71%)
USD |
NASDAQ |
Nov 14, 16:00
177.41
+0.02
(+0.01%)
After-Hours: 20:00
Krystal Biotech Free Cash Flow (Quarterly): 57.81M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 57.81M |
| June 30, 2024 | -5.299M |
| March 31, 2024 | 14.63M |
| December 31, 2023 | -9.079M |
| September 30, 2023 | -23.01M |
| June 30, 2023 | -36.98M |
| March 31, 2023 | -31.54M |
| December 31, 2022 | -27.55M |
| September 30, 2022 | -33.74M |
| June 30, 2022 | -59.57M |
| March 31, 2022 | -32.68M |
| December 31, 2021 | -61.78M |
| September 30, 2021 | -28.25M |
| June 30, 2021 | -14.12M |
| March 31, 2021 | -12.13M |
| December 31, 2020 | -15.23M |
| Date | Value |
|---|---|
| September 30, 2020 | -10.96M |
| June 30, 2020 | -7.00M |
| March 31, 2020 | -7.735M |
| December 31, 2019 | -9.279M |
| September 30, 2019 | -5.441M |
| June 30, 2019 | -5.447M |
| March 31, 2019 | -4.922M |
| December 31, 2018 | -4.822M |
| September 30, 2018 | -2.772M |
| June 30, 2018 | -1.716M |
| March 31, 2018 | -2.369M |
| December 31, 2017 | -2.286M |
| September 30, 2017 | -1.11M |
| June 30, 2017 | -0.44M |
| March 31, 2017 | -0.264M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-61.78M
Minimum
Dec 2021
57.81M
Maximum
Sep 2024
-17.67M
Average
-14.67M
Median
Free Cash Flow (Quarterly) Benchmarks
| Bioventus Inc | 10.25M |
| ADMA Biologics Inc | 23.93M |
| Alnylam Pharmaceuticals Inc | 39.52M |
| Amicus Therapeutics Inc | -23.33M |
| Apellis Pharmaceuticals Inc | 34.10M |